---
{"dg-publish":true,"permalink":"/entities/drug/semaglutide/","tags":["drug","glp1_agonist","diabetes","obesity","weight_loss","cardiovascular","prescription"]}
---


# Semaglutide

## Overview
GLP-1 receptor agonist for type 2 diabetes and obesity. Revolutionary drug providing significant weight loss and cardiovascular benefits. Available as injectable (Ozempic, Wegovy) and oral (Rybelsus).

**Short Description**: GLP-1 agonist for diabetes, weight loss, and cardiovascular protection

## Pharmacological Information

**DrugBank ID**: DB13928

**Drug Class**: GLP-1 Receptor Agonist

**Synonyms**:
- Ozempic
- Wegovy
- Rybelsus

### Mechanism of Action
Activates GLP-1 receptors, enhancing insulin, suppressing appetite, delaying gastric emptying

## Clinical Features

## Classification

## Chemical Properties
No content available.

## Relationships

No relationships found.